AAVivo, Inc., a pioneering biotechnology company developing novel, precision targeted biotherapeutics to enable in vivo generation of CAR-T cells, today announced a presentation at the Society for ...
CAZENOVIA — On Tuesday, Nov. 11, at 6:15 p.m., the Cazenovia Garden Club will welcome citizen scientist Jim English to the Cazenovia Public Library Community Room to present on the history of the ...
Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...
Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of ...
A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes ...
INDICATION AUCATZYL ® is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory B-cell precursor acute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback